Mr. John Chen is Partner of Co-win Ventures. He co-leads Co-win’s high-tech investment team, focusing on managing and investing in Hard & Core Technology sector. He has over 10 years of experience in the high-tech investment.
      Mr. Chen has led and participated in deals such as Hitronics Technologies, Jade Bird Display, Yuanjie Semiconductor, Lu-Semi, Adchem-Tech, DoiTech, Hz Electric, TetraBOT, Log56 etc.
      Prior to joining Co-win Ventures, Mr. Chen served as Process Engineer of SMIC.
      From 2012 to 2016, Mr. Chen was Investment Manager and Director of Co-win Ventures.
      Mr. Chen holds an M.S. in Material Physics and Chemistry from Nanjing University and a B.S. in Inorganic Non-metallic Materials from Jiangsu University.

      Mr. Bruce Lin is Partner and Group COO of Co-win Ventures，focusing on risk control，fund management, portfolio management and capital withdrawal. He has over 10 years of experience in venture capital and equity investment.
      Prior to joining Co-win Ventures, Mr. Lin served as Director of Jiangsu Ruihua Holdings.
      From 2016 to 2020, Mr. Lin was Investment Director and Risk Control Director of Co-win Ventures.
      Mr. Lin holds an M.S.M. in Enterprise Management from Nanjing University and a double bachelor's degree in Information Management and Publishing Science from Wuhan University.

      Mr. Johnny Sun is Partner of Co-win Ventures, focusing on the fundraising and investor relationships function. He has over 30 years of experience in marketing, finance, business management and venture capital investment. He has been engaged in venture capital since 2009. He led and participated in fundraising for more than 10 funds.
      Prior to joining Co-win Ventures, Mr. Sun served as Partner of ZAFFER and General Manager of Gold Credit Guaranty. He was Vice President of HCGA.
      Mr. Sun holds a Ph. D. in Management from Central South University and a certificate of CICPA.

      Mr. Eric Wen is Partner of Co-win Ventures. He co-leads Co-win’s healthcare investment team, focusing on managing and investing in healthcare sector. He has over 20 years of experience in clinical medicine, translational research, pharmaceutical marketing and venture capital investment.
      Mr. Wen has led and participated in deals such as Taimei technology, Genecast, Sinovation, Neuracle, Amador, Redcloud Bio, Rapid Novor, Fangcun Doctor, Neighbor Doc etc.
      Prior to joining Co-win Ventures, Mr. Wen has held a series of positions as Surgeon of Cancer Hospital of Chinese Academy of Medical Sciences, Medical Representative of Sanofi, Medical Advisor of Merck,  Medical Manager of Biotech Phama Co., Medical Director of Haodf.com and Co-founder of Quwan.com.
      From 2013 to 2016, Mr. Wen was Investment Director of Co-win Ventures.
      Mr. Wen holds an M.S. in Medicine from Peking Union Medical College.

      Ms. Cara Zhang is CFO of Co-win Ventures, focusing on the finance and operation of USD Funds. She has 10 years of experience in USD fund operation and financial management.
      Prior to joining Co-win Ventures, Ms. Zhang was Associate of GF Investments HK, China Orient Asset Management (International) and Finance Manager of Banyan Capital (Gaorong), mainly responsible for fund accounting, fund operation and fund administration for primary market PEVC funds & secondary market Fixed Income Funds.
      Ms. Zhang holds an M.S. in E‐Commerce and Logistic Technologies from CUHK and a B.E. in Finance from Shenzhen University. She is USCPA license holder and AICPA member. She was also accredited as a Certified Anti-Money Laundering Specialist by the Association of Certified Anti-Money Laundering Specialist.

      Mr. Liming Wang is Venture Partner of Co-win Ventures，focusing on healthcare investment.
      Mr. Wang is Senior Investigator and Deputy Director of Institute of Molecular Physiology, Shenzhen Bay Laboratory. His research has been focusing on the neural regulation of metabolism in various animal models. His research work has been published in high-profile journals e.g., PNAS, eLife, Nature Neurosci, Cell Res, etc. Before joining Shenzhen Bay laboratory in 2022, Mr. Wang was a tenured professor in Life Sciences Institute, Zhejiang Univertity since 2014.
      Mr. Wang is Co-founder and Managing Director of the Feng Foundation of Biomedical Research (with Mr. Xin Huang), a philanthropic foundation to support innovative biomedical research in China.
      Mr. Wang is an enthusiastic science writer and advocator, who published several well-recognized science books, including Layman’s Biology for Foodies (‘16), God’s Scissors: Human Gene Editing (‘17), What is Life (‘18), and Lectures on Evolution (‘22).
      Mr. Wang holds a Ph.D. from California Institute of Technology and a B.S. from Peking University. He was Bowes Research Fellow in UC Berkeley (‘12-‘13), and Management Consultant at BCG (‘13-‘14).

      Mr. Cheng Wang is Venture Partner of Co-win Ventures, focusing on healthcare investment. He has over 10 years research experience in molecular biology and virology and he successfully founded Innovec Biotherapeutics. Prior to joining Co-win Ventures, He was Founding Scientist of Viral Vector Technology department of Regeneron Pharmaceuticals and helped Regeneron combine their antibody technologies to build up pipelines of gene and cell therapy. Mr. Wang has obtained 7 patents which build up the gene therapy intellectual property of Regeneron.
      From 2019 to 2021, Mr. Wang was Investment Director of Co-win Ventures.
Mr. Wang holds a Ph.D. in Biological Sciences from Columbia University and a B.S. in Biological Sciences from Tsinghua University. His doctoral research works have been published in PNAS and Nature Structural and Molecular Biology.

      Ms. Vincy Chen is Vice President of Co-Win Ventures, focusing on healthcare investment.
      Ms. Chen holds an M.S. in Chemical Engineering from Columbia University and a B.E. in Chemical Engineering and Technology from Tongji University.

    Mr. Ziyu Fan is Operation Manager of Co-win Ventures，focusing on the funds’ operation and management.
    Mr. Fan holds an M.S. in Mechanics and a B.S in Civil Engineering from Xi’an University of Architecture and Technology.

      Mr. Yifeng Hou is Senior Vice President of Co-win Ventures，focusing on transportation investment.
      Mr. Hou holds an MBA from Shanghai Jiao Tong University and a B.S. in Information Management and Information System from Donghua University.

    Ms. Rachel Hu is Vice President of Co-win Ventures，focusing on healthcare investment.
    Ms. Hu holds a Ph.D. in Pharmaceutical Sciences from University of Twente, an M.S. in Pharmaceutical Sciences (Drug Innovation) from Utrecht University and a B.S. in Pharmaceutical Sciences from Peking University.

      Mr. Ke Huang is Managing Director of Co-win Ventures, focusing on semiconductor and industrial software investment. He has more than 10 years of experience in scientific research and technology development.
      Prior to joining Co-win Ventures, Mr. Huang was R&D Director of 300Cloud and had led the technical team engaging in R&D in cutting-edge fields such as artificial intelligence and high-performance computing.
      Mr. Huang holds a Ph.D. in Integrated Circuits and Systems from Tsinghua University and a B.S. in Electronic Science and Technology from the University of Electronic Science and technology. He has published many SCI papers and obtained a number of authorized patents.

      Ms. Rachel Jiao is Senior Associate of Co-Win Ventures, focusing on healthcare investment.
      Ms. Jiao has a Ph.D. in Biology from Peking University and a B.S. in Life Science from East China Normal University.

      Mr. Dylan Li is Senior Vice President of Co-win Ventures，focusing on automobiles, energy storage and new energy investment.
      Mr. Li holds an MBA from London Business School, an M.S. in Electrical and Computer Engineering from Purdue University, and a B.S. in Electrical Engineering and Automation from Huazhong University of Science and Technology.

    Mr. Liwei Lin is Senior Vice President of Co-win Ventures, focusing on high-tech and consumer investment.
    Mr. Lin holds an MBA from Shanghai Jiao Tong University and a B.S. in Statistics from Guangdong University of Finance & Economics.

    Ms. Lizzie Pu is Vice President of Co-win Ventures, focusing on financial due diligence, fund operation and data analysis.
    Ms. Pu holds a B.M. in Auditing (ACCA) from Nanjing Audit University. She is a member of CICPA and ACCA.

     Mr. Chunhui Rong is Director of Co-win Ventures, focusing on medical services, medical devices and biotech investment. He has over 10 years technical support and venture capital experience in healthcare sector.
      Prior to joining Co-win Ventures, Mr. Rong was Investment Manager of Nanjing Baoan Venture and Customer Care Specialist of Stago Diagnosis.
      From 2015 to 2020, Mr. Rong was Investment Manager and Director of Co-win Ventures.
      Mr. Rong holds an M.S. in Biomedical Engineering and a B.S. in Laboratory Medicine from Southeast University.

      Ms. Celine Shan is Senior Associate of Co-Win Ventures, focusing on healthcare investment.
      Ms. Celine Shan holds a M.S. in Biopharmaceutical and Pharmaceutical Preparations from Zhejiang University and a B.S. in Clinical Pharmacy from Harbin Medical University.

    Mr. Hai Xia is Director of Co-win Ventures, focusing on new material and new energy investment.
    Mr. Xia holds a Ph.D. in Chemistry from The Chinese University of Hong Kong and a B.S. in Polymer Materials and Engineering from University of Science and Technology of China.

      Mr. Min Xu is Senior Vice President of Co-win Ventures, focusing on new material and new energy investment.
      Mr. Xu holds an M.S. in Material Science and Engineering and a B.S. in Polymer Materials and Engineering from Tsinghua University.

    Ms. Andy Yan is Senior Associate of Co-win Ventures，focusing on the funds’ legal affairs and compliance management.
    Ms. Yan holds a LL.M. in International Economic Law from The Chinese University of Hong Kong and a LL.B. from China University of Political Science and Law. She holds a legal professional qualification certificate. 

      Ms. Yuki Yue is Senior Vice President of Co-win Ventures，focusing on the firm and funds’ legal affairs and compliance management.
      Ms. Yue holds a LL.M. in Law Theory from Nanjing Normal University and a LL.B. from Nanjing Audit University. She holds a legal professional qualification certificate.

      Mr. Aaron Zhao is Executive Director of Co-win Ventures, focusing on Optical-electro-mechanical investment. He has over 10 years of experience in optoelectronics field.
      Prior to joining Co-win Ventures, Mr. Zhao had been working in R&D and marketing departments of Philips (China) and Osram Opto Semiconductors for more than 8 years. He has rich experience in the industrialization of optoelectronic materials, devices and applications.
      Mr. Zhao holds an M.S. in Material Physics and Chemistry and a B.S. in Material Physics from Nanjing University. He has published many SCI papers and obtained two invention patents.